Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127666691 | 12766669 | 1 | I | 20151203 | 20160830 | 20160921 | 20160921 | EXP | JP-PFIZER INC-2016411190 | PFIZER | 81.00 | YR | M | Y | 0.00000 | 20160921 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127666691 | 12766669 | 1 | PS | RHEUMATREX | METHOTREXATE SODIUM | 1 | Oral | 6 MG, WEEKLY | Y | 11719 | 6 | MG | CAPSULE | /wk | |||||
127666691 | 12766669 | 2 | SS | RHEUMATREX | METHOTREXATE SODIUM | 1 | UNK | Y | 11719 | CAPSULE |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127666691 | 12766669 | 1 | Rheumatoid arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127666691 | 12766669 | LT |
127666691 | 12766669 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127666691 | 12766669 | Lip erosion | |
127666691 | 12766669 | Lip haemorrhage | |
127666691 | 12766669 | Mouth haemorrhage | |
127666691 | 12766669 | Oral mucosa erosion | |
127666691 | 12766669 | Overdose | |
127666691 | 12766669 | Pancytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127666691 | 12766669 | 1 | 201511 | 0 | ||
127666691 | 12766669 | 2 | 201512 | 0 |